Yong-Yi Zhong

机构：Sun Yat-sen University, Sun Yat-sen University Cancer Center

发表论文 16 篇 · 总被引 316 次 · h-index 6

代表论文

• Effect of Capecitabine Maintenance Therapy Using Lower Dosage and Higher Frequency vs Observation on Disease-Free Survival Among Patients With Early-Stage Triple-Negative Breast Cancer Who Had Received Standard Treatment (2020 · JAMA · 被引 233)
• The Effects of Ganglioside-Monosialic Acid in Taxane-Induced Peripheral Neurotoxicity in Patients with Breast Cancer: A Randomized Trial (2019 · JNCI Journal of the National Cancer Institute · 被引 34)
• Trastuzumab plus endocrine therapy or chemotherapy as first-line treatment for metastatic breast cancer with hormone receptor-positive and HER2-positive: The sysucc-002 randomized clinical trial. (2021 · Journal of Clinical Oncology · 被引 18)
• High-dose tamoxifen in high-hormone-receptor-expressing advanced breast cancer patients: a phase II pilot study (2021 · Therapeutic Advances in Medical Oncology · 被引 11)
• Clinical significance of serum estradiol monitoring in women receiving adjuvant aromatase inhibitor for hormone receptor-positive early breast cancer (2024 · The Breast · 被引 8)
• Metronomic capecitabine as extended adjuvant chemotherapy for early triple-negative breast cancer (SYSUCC-001): updated 10-year outcomes and post-hoc exploratory biomarker analysis from a randomised, phase 3 trial (2025 · The Lancet Oncology · 被引 6)